We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+13.46%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$368M
AUM Growth
+$90.7M
Cap. Flow
+$73.8M
Cap. Flow %
20.08%
Top 10 Hldgs %
49.24%
Holding
169
New
47
Increased
28
Reduced
11
Closed
43

Sector Composition

Rank Sector Weight
1 Communication Services 12.47%
2 Consumer Staples 11.69%
3 Healthcare 10.02%
4 Technology 6.18%
5 Financials 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSK
101
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$219K 0.06%
4,500
BDX icon
102
Becton Dickinson
BDX
$48.9B
$211K 0.06%
+1,845
New +$203K
AGN
103
DELISTED
Allergan plc
AGN
$206K 0.06%
+1,000
New +$198K
DF
104
DELISTED
Dean Foods Company
DF
$201K 0.05%
+13,000
New +$202K
WG
105
DELISTED
Willbros Group
WG
$177K 0.05%
14,000
-4,000
-22% -$38.3K
ELX
106
DELISTED
EMULEX CORP
ELX
$171K 0.05%
23,200
YONG
107
DELISTED
YONGYE INTERNATIONAL, INC. COMMON STOCK
YONG
$153K 0.04%
22,538
MCP
108
DELISTED
MOLYCORP INC COM STK
MCP
$147K 0.04%
31,400
AUY
109
DELISTED
Yamana Gold, Inc.
AUY
$132K 0.04%
+14,997
New +$145K
CCO icon
110
Clear Channel Outdoor Holdings
CCO
$1.23B
$128K 0.03%
14,000
TWGP
111
DELISTED
TOWER GROUP INTL LTD COM STK (BERMUDA)
TWGP
$94K 0.03%
+34,987
New +$94.8K
EGO icon
112
Eldorado Gold
EGO
$10.2B
$88K 0.02%
3,168
+382
+14% +$12.5K
GCVRZ
113
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$88K 0.02%
284,041
+213,871
+305% +$79.5K
OPCH icon
114
Option Care Health
OPCH
$3.67B
$70K 0.02%
2,500
NEO icon
115
NeoGenomics
NEO
$2.14B
$69K 0.02%
20,000
AUQ
116
DELISTED
AURICO GOLD INC COM
AUQ
$59K 0.02%
+13,477
New +$62.5K
BTG icon
117
B2Gold
BTG
$6.68B
$43K 0.01%
+14,406
New +$37.8K
RHE
118
DELISTED
Regional Health Properties, Inc.
RHE
$42K 0.01%
833
CYHHZ
119
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$30K 0.01%
+492,630
New +$27.3K
LXRX icon
120
Lexicon Pharmaceuticals
LXRX
$1.07B
$26K 0.01%
2,143
NIHD
121
DELISTED
NII HOLDINGS INC CL B
NIHD
$18K ﹤0.01%
15,500
AU icon
122
AngloGold Ashanti
AU
$49.2B
-13,000
Closed -$152K
GM icon
123
General Motors
GM
$77.2B
-5,000
Closed -$204K
GYRO icon
124
Gyrodyne
GYRO
$11.8M
-9,461
Closed -$1.34M
MWA icon
125
Mueller Water Products
MWA
$4.07B
-10,000
Closed -$94K

Similar funds

Gabelli & Co Investment Advisers's Q1 2014 Portfolio in Review

As of Q1 2014, Gabelli & Co Investment Advisers held 169 positions worth $368M, up 33% from $277M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Gabelli & Co Investment Advisers deployed $73.8M of net new capital in Q1 2014, opening 47 new positions and adding to 28 existing holdings. Its largest new stake was BEAM INC COM STK (DE): 444,330 shares worth $37M.

By sector, the portfolio is most concentrated in Communication Services at 12% of assets, up from 9.5% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was HEICO Corp Class A, an estimated $2.92M trimmed.

  • Gabelli & Co Investment Advisers's largest Q1 2014 buy was BEAM INC COM STK (DE): 444,330 shares worth $37M.
  • Gabelli & Co Investment Advisers added most to HI-TECH PHARMACAL INC in Q1 2014, an estimated $12.2M increase.
  • Gabelli & Co Investment Advisers's biggest Q1 2014 reduction was HEICO Corp Class A, cutting an estimated $2.92M.
  • Gabelli & Co Investment Advisers fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $30.1M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 49% of its $368M portfolio in Q1 2014.
  • Gabelli & Co Investment Advisers opened 47 new positions and closed 43 in Q1 2014.
  • Gabelli & Co Investment Advisers's portfolio value rose 33% quarter-over-quarter to $368M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2014, filed 2 May 2014.